Mutation analysis of TCGA dataset in TIMER, cBioportal, and DriverDBv3 portals shows that the Limd1 gene undergoes low rates of mutation in NSCLC (4/485 in LUSC and 4/517 in LUAD), but undergoes higher rates in DLBC (2/37), UCEC (16/531), and cholangiocarcinoma (CHOL, 1/36) (Figure 3A). This evidence concerns the gene LIMD1 and non-small cell lung carcinoma.